Related Experiment Video
Updated: Jul 18, 2026
08:28
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Risk factors for sudden unexpected death in epilepsy: a case-control study
L Nilsson1, B Y Farahmand, P G Persson
1Department of Neurological Rehabilitation, Stora Sköndal Hospital, Sweden. lena.weine@swipnet.se
Lancet (London, England)
|March 27, 1999
Summary
Sudden unexpected death in epilepsy (SUDEP) risk increases with seizure frequency and polytherapy. Early onset and frequent antiepileptic drug dose changes are also risk factors. Improving seizure control may reduce SUDEP.
Area of Science:
- Neurology
- Epilepsy Research
- Public Health
Background:
- Sudden unexpected death in epilepsy (SUDEP) is a significant concern, occurring more frequently in epilepsy patients than the general population.
- Identifying clinical variables associated with SUDEP is crucial for risk stratification and prevention.
Purpose of the Study:
- To investigate the association between clinical variables and sudden unexpected death in epilepsy (SUDEP).
- To identify specific risk factors for SUDEP in individuals with epilepsy.
Main Methods:
- A nested case-control study was conducted using a cohort of epilepsy patients aged 15-70 from Stockholm (1980-1989).
- Cases were individuals who died from epilepsy and met SUDEP criteria, with three age- and sex-matched living epilepsy patient controls per case.
- Medical records and necropsy findings were analyzed to collect and assess clinical data.
Main Results:
- Higher seizure frequency (e.g., >50 seizures/year) significantly increased SUDEP risk (RR 10.16).
- Concomitant use of three or more antiepileptic drugs (AEDs) substantially raised SUDEP risk (RR 9.89) compared to monotherapy.
- Early-onset epilepsy (RR 7.72) and frequent AED dosage changes (RR 6.08) were identified as major risk factors.
Conclusions:
- Sudden unexpected death in epilepsy (SUDEP) appears to be seizure-related, with potential predisposing factors established early in life.
- Sex differences in SUDEP risk associations were observed, with stronger links for dose changes in females.
- Improving seizure control and potentially avoiding polytherapy are recommended strategies to mitigate SUDEP risk.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:27Confounding in Epidemiological Studies
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...